Home » Israeli start-up develops meniscus replacement of tomorrow

Israeli start-up develops meniscus replacement of tomorrow

by admin

knees Not one of the many parts of the human body seems built to handle all of this “walking around, exercising, running upright”. suffers from damaged meniscal tissue, and surgery is usually required to adjust or replace the tissue and keep everything working as it should.

However, while this type of knee surgery often requires several days of recovery time for the body to heal and adjust to the adjusted area, it doesn’t last forever.

Active Implants International is a medical technology start-up that is currently developing an alternative called an artificial meniscus. new surfaceThe company’s device replaces the human meniscus and acts as a kind of pillow that sits between the knee bones and prevents grinding, rubbing, and other unpleasant friction.

“floating device”

There are other such devices, but NUsurface’s market advantage lies in its installation. It’s called a “floating device”, meaning it’s constructed in a way that doesn’t require fixing or suturing.

As a result, Dr. Eran Ganz, President of Active Implants, explains: Recovery time is significantly reduced, and besides, this device offers his competitors two additional legs: time-dependent drug release and dimensions of the device specifically tailored to the patient’s body. .

“In addition to its ability to create patient-specific implants, it also releases two drugs, one immediately after implantation and one over several months. We can immediately improve a patient’s well-being,” Ganz explains.

“In addition to its ability to create patient-specific implants, it also releases two drugs, one immediately after implantation and one over several months. We can immediately improve the patient’s well-being.”

Dr. Elan Ganz

The advantages of the device position it as a viable solution. meniscal surgery The actual feasibility of more invasive surgery is much lower in middle-aged patients than in younger patients.

On November 6, a delegation of experts, physicians and senior management directly involved in various aspects of the device’s development arrived in Israel to begin preliminary trials of the new implant and discuss ways to advance the technology. We looked at ways to speed up development. Approval and go-to-market process.

“There is a huge unmet need in the management of post-meniscectomy knee osteoarthritis from a therapeutic, especially preventive, perspective. “We have shown great ambition to address these needs by developing new techniques to treat older patients who have already developed cartilage,” said the university, president of the International Society for Cartilage Regeneration and Joint Preservation.

“We still have a lot of work ahead of us,” Ganz said. “But there is no doubt that we are at an important milestone in our journey to continually improve our current technology to continue helping more patients around the world.”

You may also like

Leave a Comment